Misplaced Pages

This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (April 2022) (Learn how and when to remove this message)

Vikki Martyne Abrahams is an English–American reproductive immunologist. She is a full professor of obstetrics, gynecology and reproductive sciences at the Yale School of Medicine. Her research focuses on understanding the role of innate immune toll-like receptor and NOD-like receptor family members in placental and maternal-fetal immune responses.

Early life and education

Abrahams earned her Bachelor of Science degree and PhD from the University College London.

Career

Abrahams came to the United States for her postdoctoral work at Dartmouth Medical School and Yale University in the field of reproductive immunology before accepting a faculty position in 2004. In her role as an assistant professor of obstetrics and gynecology, Abrahams co-authored a study which found that there was a specific defence mechanism used by the immune system which was imitated by cancer cells in order to fight off the effects of cancer drugs like paclitaxel. She was later awarded a one-year grant of $73,284 from the Lupus Research Alliance for her project titled "Effect of Antiphospholipid Antibodies on Trophoblast Function in Pregnancy." In 2010, Abrahams continued her research into pregnancy complications using a three-year grant from the American Heart Association to advance her work. She also co-authored another study which uncovered how hormone progesterone act to prevent preterm birth.

Abrahams research focuses on understanding the role of innate immune toll-like receptor and NOD-like receptor family members in placental and maternal-fetal immune responses. In 2014, she was the senior author on a study exploring whether an anti-malaria drug could be used to treat obstetrical antiphospholipid syndrome. Two years later, she was the recipient of the 2016 Novel Research Grant from the Lupus Research Institute to conduct innovative work in lupus. She used this grant to lead a study identifying how the Zika virus infects the placenta.

In 2019, Abrahams was the recipient of the annual American Society for Reproductive Immunology Award as someone "who has made outstanding contributions to the area of reproductive immunology."

References

1. ^ "Vikki Abrahams, PhD". medicine.yale.edu. Retrieved November 17, 2020.
2. "New Clues to Drug Resistance in Ovarian Cancer". news.yale.edu. May 24, 2006. Retrieved November 17, 2020.
3. "Abrahams receives grant to study women with APS". news.yale.edu. January 14, 2009. Retrieved November 17, 2020.
4. "Vikki Abrahams receives AHA grant". news.yale.edu. July 15, 2010. Retrieved November 17, 2020.
5. "Yale Researchers May Have Uncovered the Mechanism By Which Progesterone Prevents Preterm Birth". news.yale.edu. February 5, 2010. Retrieved November 17, 2020.
6. Peart, Karen (January 21, 2014). "Malaria drug combo could help prevent pregnancy complications in lupus patients". medicine.yale.edu. Retrieved November 17, 2020.
7. "Reproductive immunologist Vikki Abrahams awarded novel grant to study lupus". medicine.yale.edu. January 20, 2016. Retrieved November 17, 2020.
8. Kashef, Ziba (August 18, 2016). "Yale study identifies how Zika virus infects the placenta". news.yale.edu. Retrieved November 17, 2020.
9. "Dr. Vikki Abrahams receives the 2019 American Society for Reproductive Immunology Award". medicine.yale.edu. June 18, 2019. Retrieved November 17, 2020.

External links

Vikki Abrahams publications indexed by Google Scholar

• Living people
• Alumni of University College London
• Yale University faculty
• Yale School of Medicine faculty
• American immunologists
• Women immunologists
• 21st-century American women physicians
• 21st-century American physicians
• American women academics